|
Gilles Gallant joined HGS in June 2002 as Vice President Oncology Drug Development. Prior to joining HGS Dr. Gallant was Director of Clinical Oncology at Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Gallant joined Bristol-Myers Squibb in 1991 and advanced through a succession of research management positions. He played a key role in designing and directing registrational and non-registrational clinical trials of Bristol-Myers Squibb’s oncology products in the United States Europe and Canada. Dr. Gallant received his doctorate in medicinal chemistry and bachelor’s degree in pharmacy from the Université de Montreal in Montréal Canada. He has co-authored numerous scientific abstracts and peer-reviewed publications in the oncology research field and is an active member of the American Society of Clinical Oncology and the American Association for Cancer Research. | 